Inactive Instrument

Analyst Reco. Reviva Pharmaceuticals Holdings, Inc. Nasdaq

Equities

HC Wainwright Raises Reviva Pharmaceuticals' Price Target to $20 From $10, Keeps Buy Rating	31/23/31	MT
Roth MKM Initiates Reviva Pharmaceuticals With Buy Rating, Price Target is $12	20/23/20	MT
Benchmark Initiates Reviva Pharmaceuticals at Speculative Buy With $17 Price Target	08/23/08	MT
Maxim Adjusts Price Target on Reviva Pharmaceuticals Holdings to $18 From $10, Maintains Buy Rating	03/23/03	MT
Fed Rate Increase Drags Exchange-Traded Funds, Stock Futures Lower Premarket Thursday	15/22/15	MT
Alliance Global Starts Reviva Pharmaceuticals Holdings at Buy With $16 Price Target	01/22/01	MT
Maxim Group Adjusts Price Target on Reviva Pharmaceuticals Holdings to $10 From $3, Maintains Buy Rating	01/22/01	MT
Maxim Lowers Price Target for Reviva Pharmaceuticals Holdings to $3 From $5, Maintains Buy Rating	28/22/28	MT
HC Wainwright Starts Reviva Pharmaceuticals Holdings at Buy With $10 Price Target	24/22/24	MT
Today on Wall Street: More rate hikes expected this year	10/22/10
REVIVA PHARMACEUTICALS : Maxim Group Initiates Reviva Pharmaceuticals at Buy Rating With $10 Price Target	26/21/26	MT

No results for this search